Muscarinic agonists as cognitive enhancers
Download pdf
Abstract/Description: | Methods of treating a mental condition by administering to a subject in need thereof an effective amount of compound CDD-102A, [5-(3-ethyl-1,2,4-oxadiazol-5-yl)-1,4,5,6-tetrahydropyrimidine] are described. |
---|---|
Subject(s): | A61K31/506 |
Date Issued: | 2020-11-17 |
Title: | Muscarinic agonists as cognitive enhancers. |
|
---|---|---|
Name(s): |
Messer Jr., William S., inventor Ragozzino, Michael E., inventor The University of Toledo, assignee The Board of Trustees of the University of Illinois, assignee |
|
Type of Resource: | text | |
Genre: | patent | |
Date Issued: | 2020-11-17 | |
Other Date: | Date Filed: 2013-10-17 | |
Publisher: | United States Patent and Trademark Office | |
Physical Form: | application/pdf | |
Extent: | 21 p. | |
Abstract/Description: | Methods of treating a mental condition by administering to a subject in need thereof an effective amount of compound CDD-102A, [5-(3-ethyl-1,2,4-oxadiazol-5-yl)-1,4,5,6-tetrahydropyrimidine] are described. | |
Identifier(s): |
utpatents-US10835532 (IID) Patent No.: US10835532 (patno) Appl. No.: 14/056616 (appno) |
|
Subject(s): | A61K31/506 | |
Held by: | United States Patent and Trademark Office (USPTO) Public Search Facility | |
Location: | University of Toledo Digital Repository | |
Rights Statement: | No Copyright - United States | |
In Collections: |